These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS). Walton SE; Krotulski AJ; Logan BK J Anal Toxicol; 2022 Mar; 46(3):221-231. PubMed ID: 34792157 [TBL] [Abstract][Full Text] [Related]
9. Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays. Vandeputte MM; Persson M; Walther D; Vikingsson S; Kronstrand R; Baumann MH; Gréen H; Stove CP Arch Toxicol; 2022 Mar; 96(3):877-897. PubMed ID: 35072756 [TBL] [Abstract][Full Text] [Related]
10. In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling. Tsai MM; Chen L; Baumann MH; Canals M; Javitch JA; Lane JR; Shi L ACS Chem Neurosci; 2024 Feb; 15(4):854-867. PubMed ID: 38345920 [TBL] [Abstract][Full Text] [Related]
11. Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review. Montanari E; Madeo G; Pichini S; Busardò FP; Carlier J Ther Drug Monit; 2022 Aug; 44(4):494-510. PubMed ID: 35149665 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists. De Luca MA; Tocco G; Mostallino R; Laus A; Caria F; Musa A; Pintori N; Ucha M; Poza C; Ambrosio E; Di Chiara G; Castelli MP Neuropharmacology; 2022 Dec; 221():109263. PubMed ID: 36154843 [TBL] [Abstract][Full Text] [Related]
13. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"? Napoletano S; Basile G; Lo Faro AF; Negro F Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997 [TBL] [Abstract][Full Text] [Related]
14. In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances. Vandeputte MM; Cannaert A; Stove CP Arch Toxicol; 2020 Nov; 94(11):3819-3830. PubMed ID: 32734307 [TBL] [Abstract][Full Text] [Related]
15. DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles. Ujváry I; Christie R; Evans-Brown M; Gallegos A; Jorge R; de Morais J; Sedefov R ACS Chem Neurosci; 2021 Apr; 12(7):1072-1092. PubMed ID: 33760580 [TBL] [Abstract][Full Text] [Related]
16. Analytical characterization of "etonitazepyne," a new pyrrolidinyl-containing 2-benzylbenzimidazole opioid sold online. Blanckaert P; Balcaen M; Vanhee C; Risseeuw M; Canfyn M; Desmedt B; Van Calenbergh S; Deconinck E Drug Test Anal; 2021 Sep; 13(9):1627-1634. PubMed ID: 34145779 [TBL] [Abstract][Full Text] [Related]
17. Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats. Walton SE; Krotulski AJ; Glatfelter GC; Walther D; Logan BK; Baumann MH Psychopharmacology (Berl); 2023 Jan; 240(1):185-198. PubMed ID: 36526866 [TBL] [Abstract][Full Text] [Related]
18. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats. Walker EA; Young AM Psychopharmacology (Berl); 2001 Mar; 154(2):131-42. PubMed ID: 11314675 [TBL] [Abstract][Full Text] [Related]